NANEXA Share Price Performance
SEK 2.09
0.61 (41.84%)
60.4% overvalued intrinsic discount
SEK 1.30
Fair Value
Price SEK 2.09
daemningen4500 SEK 1.30
Fair ValueSEK 1.30
Share PriceSEK 2.09
60.4% overvalued intrinsic discount
Nanexa AB (publ) Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 10 Fair Values set on narratives written by author
NANEXA Community Narratives
DA
Fair Value SEK 1.3 60.0% overvalued intrinsic discount
19,9% Novo Nordisk ownership on a small swedish biotech - could this be a significant technology?
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Nanexa AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 06, 2025
- Earnings per share (EPS)
- -0.20
- Gross Margin
- 57.93%
- Net Profit Margin
- -80.61%
- Debt/Equity Ratio
- 24.0%
Nanexa AB (publ) Competitors
Snowflake Analysis
About NANEXA
- Founded
- 2007
- Employees
- 15
- CEO
- WebsiteView website
Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, rest of Europe, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that has completed Phase I trial for the treatment of type 2 diabetes; NEX-18, a depot drug from azacitidine to treat myelodysplastic syndrome; and NEX-20, a depot drug from lenalidomide for the treatment of multiple myeloma. The company has collaborations with Novo Nordisk and AstraZeneca for the development of pharmaceutical products with active substances. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Swedish Market Performance
- 7 Days: 1.9%
- 3 Months: 1.2%
- 1 Year: -0.5%
- Year to Date: 3.3%
Over the last 7 days, the market has risen 1.9%, driven by gains of 3.2% in the Industrials sector. In the last 12 months, the market has been flat. Looking forward, earnings are forecast to grow by 16% annually. Market details ›